Dusti buys ANIP 37.32: ANI Pharma (ANIP) Enters Exclusive License, Supply Pact with Dexcel
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) as signed an exclusive license and supply agreement with Dexcel Pharma Technologies Ltd. ("Dexcel") for an ANDA drug product. Dexcel submitted the ANDA application in December 2011. Dexcel will be responsible for .. ...
40 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home